Theauthors concluded that a subdepressive dose of kallikrein or BK could restore impairedcardiac function in rats with post-infarction HF by inhibiting hypertrophy and fibrosisand promoting angiogenesis through increased nitric oxide formation and suppression ofoxidative stress and TGF-β1 expression. The gene discussed is KLK4; the disease is hydrops fetalis.